HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesBms 906024
Chemical structure of CAS 1401066-79-2

Bms 906024

In Stock•Starting at $776 for 1 mg
CAS No.1401066-79-2
MDL No.MFCD24849414
MFC26H26F6N4O3
MW556.50
InChI KeyAYOUDDAETNMCBW-GSHUGGBRSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$776In Stock
5 mgTo Be Confirmed$1641In Stock
10 mgTo Be Confirmed$2201In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

(2S,3R)-N'-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide is a primary, secondary, and tertiary carboxamide.

CAS No.1401066-79-2
Product NameBms 906024

Associated Conditions

breast cancer·acute lymphoblastic leukemia·neoplasm·precursor T-cell lymphoblastic leukemia-lymphoma·cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.

Cold Spring Harbor molecular case studies • Vol. 1, Issue 1 • 2015
PMID: 27148573PMC: PMC4850884DOI: 10.1101/mcs.a000539

Documentation

Similar Products